![Christian Itin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Itin
Amministratore Delegato presso
AUTOLUS THERAPEUTICS PLC
Patrimonio netto: 3 M $ in data 31/08/2026
Profilo
Christian Martin Itin is the founder of Zyomyx, Inc. (1998).
Dr. Itin is currently the Chief Executive Officer of Autolus Ltd. (2021), Chief Executive Officer & Director of Autolus Therapeutics Plc (2021), Director of Innate Pharma SA (2025), Director of Kymab Group Ltd. (2016), and Director of Autolus Holdings (UK) Ltd. (2018).
Former positions include Chairman, CEO & Head-Media Relations at Cytos Biotechnology AG (2012-2016), Chief Executive Officer at Micromet AG (2006), President, Chief Executive Officer & Director at Amgen Rockville, Inc. (2011-2012), Non-Executive Director at Kymab Ltd. (2012-2021), Non-Executive Director at Zyngenia, Inc. (2013-2014), and Director at Kuros Biosciences Ltd. (2018-2019).
Education includes a doctorate from the University of Basel.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 1.166.009 ( 0,44% ) | 3 M $ | 31/08/2026 |
Posizioni attive di Christian Itin
| Società | Posizione | Inizio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Amministratore Delegato | 01/03/2016 |
| INNATE PHARMA | Direttore/Membro del Consiglio | 22/05/2025 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Amministratore Delegato | 01/03/2016 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Direttore/Membro del Consiglio | 23/11/2016 |
Autolus Holdings (UK) Ltd.
 Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Operates as holding company whose subsidiaries engages in pharmaceutical research and development activities | Direttore/Membro del Consiglio | 15/06/2018 |
Precedenti posizioni note di Christian Itin
| Società | Posizione | Fine |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Direttore/Membro del Consiglio | 01/01/2021 |
| KUROS BIOSCIENCES AG | Presidente | 01/06/2018 |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Amministratore Delegato | 01/01/2016 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Amministratore Delegato | 02/03/2012 |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Christian Itin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
66
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | Health Technology |
Zyomyx, Inc.
 Zyomyx, Inc. Medical SpecialtiesHealth Technology Designs and manufactures point-of-care diagnostic devices | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Kuros Biosciences Ltd.
 Kuros Biosciences Ltd. Medical SpecialtiesHealth Technology Manufactures medical device technology and provides clinical research development services | Health Technology |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Autolus Holdings (UK) Ltd.
Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Operates as holding company whose subsidiaries engages in pharmaceutical research and development activities | Health Technology |
